Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.85 USD | +0.34% | -8.34% | -12.59% |
02:00pm | Goldman Sachs Cuts Bristol-Myers Squibb's Price Target to $56 From $60 | MT |
12:54pm | Deutsche Bank Adjusts Price Target on Bristol-Myers Squibb to $53 From $55, Keeps Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.59% | 90.92B | |
+25.83% | 661B | |
+26.73% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.60% | 231B | |
+5.31% | 200B | |
-8.96% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Morgan Stanley Trims Price Target on Bristol-Myers Squibb to $41 From $42, Incorporates Mirati Transaction Into Model; Underweight Kept